STAT

FEBRUARY 27, 2025

Biotech venture capital is on the precipice of a generational shift. At least, that’s according to the crowd of younger firm founders edging their way in. There’s long been a small batch of scientists and business leaders who invest in drug companies. For the first 15 years of the 21st century, you’d find only 400, maybe 450 VC firms regularly giving money to drug startups — biotech’s own version of The Four Hundred , with lab coats or branded polar fleece, rat

Drug Development 303

Drug Development 303

The Pharmacist

FEBRUARY 27, 2025

Peers in the House of Lords have voted to exempt pharmacies from having to pay increased National Insurance contributions (NICs) from April. The amendment to the National Insurance Contributions (Secondary Class 1 Contributions) Bill says that specified employers, including those contracted to provide NHS pharmacy services, should only need to contribute 13.8%.

115

115

STAT

FEBRUARY 27, 2025

This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up  here  to get it delivered to their inbox. Health care investor Kevin Tang buys “zombie” biotechs to shut them down. It’s a counterintuitive, but ingenious solution to the sector’s intractable problem  covered in last week’s newsletter.

Drug Development 288

Drug Development 288

The Pharmacist

FEBRUARY 27, 2025

A committee of influential MPs has called for an update on the highly anticipated economic review of community pharmacy in England. The Health and Social Care Committee (HSCC) has today asked NHS England to share when it anticipates the economic analysis of the community pharmacy sector will be fully completed, and if it intends to […] The post MPs ask NHS England if, when and how it will publish economic review of pharmacy appeared first on The Pharmacist.

Community Pharmacies 110

Community Pharmacies 110

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

STAT

FEBRUARY 27, 2025

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds.  Sign up here. Can you believe the temperature in Boston hit the 50s yesterday? It’s the first false start to spring, and I’m sure that there are more cold days ahead of us. But still, it was so, so sweet.

232

232

PharmaVoice

FEBRUARY 27, 2025

Recursion CFO Ben Taylor discusses the state of AI M&A and what companies should look for as the industry moves to new data technologies and systems.

200

200

Pharma Marketing Network

FEBRUARY 27, 2025

Introduction In todays fast-paced world, pharma digital marketing is more than just a strategyit’s a necessity. With increasing competition, strict regulations, and changing consumer behavior, pharmaceutical brands must embrace digital transformation to stay relevant. But how can pharma marketers break through the noise, engage their audience, and see real ROI?

HIPAA 52

HIPAA Diabetes Pharmaceutical Companies Pharmaceutical Companies 52

Express Pharma

FEBRUARY 27, 2025

Global pharma company Lupin has been included in the S&P Global Sustainability Yearbook 2025 for the second consecutive year. The recognition is based on Lupins Corporate Sustainability Assessment (CSA) score for 2024, ranking it within the top 10 per cent of its industry. The S&P Global Sustainability Yearbook selects companies based on their CSA scores, evaluating their performance in sustainability.

66

66

Drug Patent Watch

FEBRUARY 27, 2025

Navigating the Complex World of Global Drug Patents: Strategies and Challenges Ahead As a pharmaceutical professional, you know how crucial it is to protect your innovative drug patents in the global market. With the rise of international trade and the increasing complexity of patent laws, it's more challenging than ever to safeguard your intellectual property.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

European Pharmaceutical Review

FEBRUARY 27, 2025

Researchers at Pohang University of Science and Technology (POSTECH), South Korea, have developed a super-photostable organic dye. The discovery sets a new benchmark for organic fluorophores, Professor Young-Tae Chang explained, providing potential applications in broad areas such as drug development and cellular imaging. Single-molecule imaging uses fluorescent markers to track proteins with precision.

Drug Development 52

Drug Development 52

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

pharmaphorum

FEBRUARY 27, 2025

An FDA advisory committee due to be held in March to discuss the formulation of influenza vaccines for the 2025/26 flu season has been cancelled.

Vaccines 110

Vaccines 110

World Pharma News

FEBRUARY 27, 2025

GSK plc (LSE/NYSE: GSK) announced that it has completed the acquisition of IDRx, Inc. (IDRx), a Boston-based, clinical-stage biopharmaceutical company dedicated to developing precision therapeutics for the treatment of gastrointestinal stromal tumours (GIST). As announced previously(1), the acquisition includes lead molecule IDRX-42, an investigational, highly selective tyrosine kinase inhibitor (TKI) that is designed to improve outcomes for patients with GIST.

108

108

BioPharma Dive

FEBRUARY 27, 2025

The meeting, which helps the FDA give guidance to vaccine makers on which flu strains to target, is the second to be disrupted since Robert F. Kennedy Jr. was sworn in as health secretary.

Vaccines 108

Vaccines 108

Pharmaceutical Business Review

FEBRUARY 27, 2025

Carrying the Chinese trade name of Wan Ti Le, the tablets are indicated for individuals who have either insufficient response or cannot tolerate phosphorus binders. They are claimed to be the first to gain approval in the country, paving the way for multi-mechanism synergistic phosphate control while providing hope for individuals with hyperphosphatemia on haemodialysis in the country.

52

52

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

Safe Biologics

FEBRUARY 27, 2025

On February 25th, ASBM’s Immediate Past Chair Madelaine Feldman, MD FACR joined Members of Congress and other high-profile supporters of PBM reform at a Congressional event urging leadership to include critical bipartisan PBM reform legislation in the anticipated March funding package. The event, titled “Finish the Job! Pass PBM Reform Now” included welcome remarks from Rep.

Packaging 100

Packaging 100

FDA Law Blog: Biosimilars

FEBRUARY 27, 2025

The American Conference Institutes popular FDA Boot Camp now in its 43rd iteration is scheduled to take place from March 19-20, 2025, at the NY Bar Association in New York, NY. The conference is billed as the premier event to provide folks with a roadmap to navigate the difficult terrain of FDA regulatory law. And it is exactly that! The conference equips legal professionals without prior regulatory experience, as well as life sciences executives involved with FDA-regulated products, with a

59

59

Pharma Times

FEBRUARY 27, 2025

New collaboration aims to integrate AI solutions for treatment

98

98

The Script

FEBRUARY 27, 2025

Trying to determine your current staffing efficiency? Our team at Rx relief discusses three metrics managers should be measuring.

Pharmacy Management 83

Pharmacy Management 83

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

pharmaphorum

FEBRUARY 27, 2025

Kyorin Pharma has signed a deal with Hyfe to develop a digital therapeutic (DTx) for people with chronic cough and launch it in Japan.

81

81

BioPharma Dive

FEBRUARY 27, 2025

Verve offered few details on the early end of a collaboration the companies inked in 2022, saying only that Vertex cited “changing priorities.

69

69

pharmaphorum

FEBRUARY 27, 2025

Discover how digital health technologies and collaboration are driving innovation in the field of rare diseases. Learn more about the latest advancements and how they are improving patient outcomes and access to care.

71

71

Pharmaceutical Technology

FEBRUARY 27, 2025

Pfizer has ended the global commercialisation of its haemophilia B (factor IX deficiency) gene therapy Beqvez, citing soft demand for gene therapies among haemophilia patients and physicians.

66

66

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

pharmaphorum

FEBRUARY 27, 2025

Regeneron has refiled its CD20xCD3 bispecific odronextamab for lymphoma with the FDA, which was rejected last year, but is seeking a narrower label.

Labelling 64

Labelling 64

Pharmaceutical Technology

FEBRUARY 27, 2025

Eli Lilly has announced plans to expand its domestic medicine production in the US with four new pharmaceutical manufacturing sites.

Pharmaceutical Manufacturing 66

Pharmaceutical Manufacturing 66

Pharmaceutical Commerce

FEBRUARY 27, 2025

In the second part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Geoffrey Joyce, PhD, director of health policy at the Leonard D. Schaeffer Center for Health Policy & Economics at USC, details the factors that could makes the generic drug market susceptible to supply chain disruptions.

Drug Pricing 59

Drug Pricing 59

Pharmaceutical Technology

FEBRUARY 27, 2025

The MSSG solidarity mechanism enables medicine sharing between EU states, with companies now required to report on drug stocks.

59

59

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

pharmaphorum

FEBRUARY 27, 2025

UK-listed pharma company Indivior has appointed pharma veteran Joe Ciaffoni as its new chief executive, replacing Mark Crossley

59

59

Pharmaceutical Technology

FEBRUARY 27, 2025

New EU Clinical Trial Regulations simplify international trials while offering the means to counter drug shortages for trials in Europe.

59

59

Pharma Marketing Network

FEBRUARY 27, 2025

Introduction In todays fast-evolving digital landscape, programmatic display ads are transforming the way pharma brands reach healthcare professionals (HCPs), patients, and stakeholders. Gone are the days of broad, one-size-fits-all advertising. Instead, real-time bidding, AI-driven targeting, and data analytics ensure that every ad impression reaches the most relevant audience.

HIPAA 52

HIPAA Diabetes 52

Pharmaceutical Technology

FEBRUARY 27, 2025

Zevra will use the $150m to support the commercial launches of rare disease drugs Miplyffa and Olpruva.

59

59

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management